Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Apr 15:16:1601477.
doi: 10.3389/fphar.2025.1601477. eCollection 2025.

Editorial: Emerging trends in real-world pharmacoepidemiology: 2023

Mohammed S Salahudeen  1 , Tatiane Da Silva Dal Pizzol  2   3 , Li-Ting Kao  4 , Gregory M Peterson  1
Affiliations
Editorial

Editorial: Emerging trends in real-world pharmacoepidemiology: 2023

Mohammed S Salahudeen et al. Front Pharmacol. .
No abstract available

Keywords: big data; electronic health records; medication safety; patient safety; pharmacoepidemiology (MeSH); population-level; real-world; real-world data (RWD).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Emerging trends in real-world pharmacoepidemiology: 2023

References

    1. Alowais S. A., Alghamdi S. S., Alsuhebany N., Alqahtani T., Alshaya A. I., Almohareb S. N., et al. (2023). Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med. Educ. 23, 689. 10.1186/s12909-023-04698-z - DOI - PMC - PubMed
    1. Chaabene S., Boudaya A., Bouaziz B., Chaari L. (2025). An overview of methods and techniques in multimodal data fusion with application to healthcare. Int. J. Data Sci. Anal. 2020. 10.1007/s41060-025-00715-0 - DOI
    1. Chedid V., Vijayvargiya P., Camilleri M. (2018). Advantages and limitations of the federal adverse events reporting System in assessing adverse event reporting for eluxadoline. Clin. Gastroenterol. Hepatol. 16, 336–338. 10.1016/j.cgh.2017.11.025 - DOI - PMC - PubMed
    1. Dimakos J., Douros A. (2024). Methodological considerations on the use of cohort designs in drug-drug interaction studies in pharmacoepidemiology. Curr. Epidemiol. Rep. 11, 175–183. 10.1007/s40471-024-00347-1 - DOI
    1. Fusaroli M., Salvo F., Begaud B., Alshammari T. M., Bate A., Battini V., et al. (2024). The REporting of A disproportionality analysis for DrUg safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration. Drug Saf. 47, 585–599. 10.1007/s40264-024-01423-7 - DOI - PMC - PubMed

Publication types

LinkOut - more resources